U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284953) titled 'A Novel Haemostatic Agent for Robotic Partial Nephrectomy' on Nov. 14.
Brief Summary: Kidney cancer is one of only a few cancers with an increasing incidence over the past two decades. Renal cell carcinoma (RCC) accounts for over 85% of all kidney tumours, which makes up 2-3% of all adult malignancies. Approximately, 70% of RCCs are incidentally discovered on axial imaging of the abdomen with >50% of RCCs being low-stage (T1-T2 N0M0). Despite advancements in drug discovery for advanced RCC, mortality rates have not changed over the past two decades, however for patients with the low-stage disease, surgical extirpation offers excelle...